These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2670583)

  • 1. Tumour spheroid technology in cancer therapy research.
    Carlsson J; Nederman T
    Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1127-33. PubMed ID: 2670583
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of tumour cell growth by a novel dihydropyridine derivative.
    Gietzen K; Abdallah F; Bai G
    Eur J Cancer; 1990; 26(8):922-3. PubMed ID: 2145943
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumour cell morphometry and response to chemotherapy in ovarian cancer.
    Weger AR; Ludescher C; Mikuz G; Hausmaninger H; Lindholm J
    Lancet; 1988 Oct; 2(8618):1020-1. PubMed ID: 2902454
    [No Abstract]   [Full Text] [Related]  

  • 4. The evolution of curative cancer therapy.
    Frei E
    Mt Sinai J Med; 1992 Oct; 59(5):408-11. PubMed ID: 1435837
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined modality therapy using cytotoxic agents and radiation therapy.
    Howes AE; Coleman CN; Phillips TL; Sutherland R
    Am J Clin Oncol; 1988 Jun; 11(3):304-12. PubMed ID: 3289363
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of agents that induce apoptosis of multicellular tumour spheroids: enrichment for mitotic inhibitors with hydrophobic properties.
    Fayad W; Rickardson L; Haglund C; Olofsson MH; D'Arcy P; Larsson R; Linder S; Fryknäs M
    Chem Biol Drug Des; 2011 Oct; 78(4):547-57. PubMed ID: 21726416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemosensitivity testing with highly purified fresh human tumour cells with the MTT colorimetric assay.
    Yamaue H; Tanimura H; Tsunoda T; Tani M; Iwahashi M; Noguchi K; Tamai M; Hotta T; Arii K
    Eur J Cancer; 1991; 27(10):1258-63. PubMed ID: 1835595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Temperature dependence of cytostatic drug effect. Metabolic milieu and tumor oxygenation with hyperthermia].
    Wiedemann GJ
    Fortschr Med; 1995 Apr; 113(11):166. PubMed ID: 7768480
    [No Abstract]   [Full Text] [Related]  

  • 9. Antineoplastic drugs in 1990. A review (Part II).
    Black DJ; Livingston RB
    Drugs; 1990 May; 39(5):652-73. PubMed ID: 2191847
    [No Abstract]   [Full Text] [Related]  

  • 10. CXCR4 expression during tumour cell death.
    Skommer J; Wlodkowic D; Pelkonen J
    Leuk Res; 2007 Aug; 31(8):1155-6. PubMed ID: 17064769
    [No Abstract]   [Full Text] [Related]  

  • 11. Protease inhibitors in chemoprevention of cancer. An overview.
    Das S; Mukhopadhyay P
    Acta Oncol; 1994; 33(8):859-65. PubMed ID: 7818916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a human tumour cell line panel for screening of anti-tumour agents in vitro.
    Fricker SP; Buckley RG
    Biochem Soc Trans; 1989 Dec; 17(6):1049-50. PubMed ID: 2628072
    [No Abstract]   [Full Text] [Related]  

  • 13. The anti-cancer activity of tumour necrosis factor.
    Malik S; Balkwill F
    Ann Inst Pasteur Immunol; 1988; 139(3):285-8. PubMed ID: 3048310
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug resistance in tumor cells.
    Giulioni MA; Giorgi FC; Piga A; Gramazio A; Cellerino R
    Rays; 1993; 18(3):330-9. PubMed ID: 7904371
    [No Abstract]   [Full Text] [Related]  

  • 15. Methodological artifacts in the assessment for (anti-) proliferative activities of mistletoe extracts.
    Kelter G; Fiebig HH; Schierholz JM; Fischer IU
    Pediatr Blood Cancer; 2007 Jul; 49(1):105; author reply 106. PubMed ID: 16830332
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of a new model of human prostatic cancer: the multicellular tumor spheroid.
    Donaldson JT; Tucker JA; Keane TE; Walther PJ; Webb KS
    Int J Cancer; 1990 Aug; 46(2):238-44. PubMed ID: 2200753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identification of resistance factors is a step towards optimized treatment with cytostatic agents].
    Ringborg U
    Lakartidningen; 1990 May; 87(21):1880-2. PubMed ID: 2362478
    [No Abstract]   [Full Text] [Related]  

  • 18. Ingredient in green tea kills prostate cancer cells, study finds.
    Mayo Clin Health Lett; 1999 Apr; 17(4):4. PubMed ID: 10100462
    [No Abstract]   [Full Text] [Related]  

  • 19. [Perspectives on modulation of chemoresistance of malignant diseases].
    Allerödder HP; Ukena D; Sybrecht GW
    Pneumologie; 1993 Sep; 47(9):513-7. PubMed ID: 7901849
    [No Abstract]   [Full Text] [Related]  

  • 20. [Multidrug resistance].
    Donenko FV; Sitdikova SM; Moroz LV
    Vopr Onkol; 1991; 37(7-8):780-8. PubMed ID: 1842629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.